Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-028741

Director sold 2,000 shares at $245.65 ($491,300)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FARRELL PETER C Director 2024-12-04 Sale 10b5-1 −2,000 $245.65 $491,300 81,218 D: show line 1 in the form
Open-market sales · 2,000 sh · avg $245.65 · $491,300
Loading xslF345X05/form4.xml…